completed
ACTIVE BETWEEN: 2017-2022

Increased Access to Cancer Treatments across Africa, Asia & Latin America

To expand access to an affordable portfolio of essential oncology treatments in selected countries across Africa, Asia & Latin America
SGDS CONTRIBUTING TO:
SHOW SUB-TARGETS + HIDE SUB-TARGETS -
MEMBER COMPANIES:
Global NGOs 1
Local NGOs 1
Objectives
  • Expand access to eleven essential cancer medications in Ethiopia, Nigeria, Kenya, Uganda, Rwanda and Tanzania.

Cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018. Approximately 70% of deaths from cancer occur in low- and middle-income countries. Late-stage presentation and inaccessible diagnosis and treatment are common. In 2017, only 26% of low-income countries reported having pathology services generally available in the public sector. More than 90% of high-income countries reported treatment services are available compared to less than 30% of low-income countries. This leads to very low 5-year survival rates in low-income countries. In addition, only 1 in 5 low- and middle-income countries have the necessary data to drive cancer policy. (i).

(i) https://www.who.int/news-room/fact-sheets/detail/cancer- Accessed September 11th 2019

The Partnership

In collaboration with the Clinton Health Access Initiative (CHAI) and the American Cancer Society, the partnership is focused on:

  • Ensure affordable access to essential medicines, technology and infrastructure.
  • Improve procurement planning
    and forecasting by leveraging innovative technology
  • Provide access to high-quality, essential medicines and a secure supply chain

 

Quote
"At Pfizer, we are proud to work with the American Cancer Society and the Clinton Health Access Initiative to improve the availability of these crucial treatments for patients."
Richard Blackburn
Global President, Europe, Africa, Middle East, and Biosimilars, Pfizer Essential Health
Results and milestones

The program has officially been launched across sub-Sahara Africa with patients treated in Nigeria & Ethiopia. We are expecting to expand the program across Africa and to selected countries in Asia and Latin America.

Geographic Reach
  • Africa
  • Americas
  • South-East Asia
See Where
Disease Area
  • Non-communicable diseases
See Disease Areas
Target Population
  • People with low incomes
Partner organizations
Global NGOs

Clinton Health Access Initiative (CHAI)

Local NGOs

American Cancer Society